Abundant circulating lipids — a new opportunity for NSCLC detection?

Nature Reviews Clinical Oncology, Published online: 28 March 2022; doi:10.1038/s41571-022-00621-5Non-small-cell lung cancer (NSCLC) is a growing public-health threat, with one of the highest mortality risks among non-communicable diseases. Now, researchers have developed a diagnostic tool for NSCLC by mass spectrometry of a targeted panel of lipids. Herein, we discuss key aspects that could facilitate the clinical implementation of this and similar tools in other fields of application.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Source Type: research